Navigation Links
Hospira to Present at Upcoming Investor Conferences
Date:2/14/2011

LAKE FOREST, Ill., Feb. 14, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at two upcoming conferences:


  • Raymond James 32nd Institutional Investors Conference


  • March 8, 2011 (Tuesday) – Orlando, Fla.  9:15 a.m. Eastern time


  • Barclays Capital 2011 Global Healthcare Conference


  • March 16, 2011 (Wednesday) – Miami, Fla.:45 a.m. Eastern timeThe presentations will be available to all interested parties through live audiocasts accessible via the investor relations section of Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance of each presentation to ensure proper setup to receive the audiocast. The slides accompanying the presentations will also be available on the Hospira Web site. Replays of the webcasts will be available on the Hospira Web site approximately 24 hours after the live presentations.

    Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.


    '/>"/>
    SOURCE Hospira, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1

    Related medicine technology :

    1. Hospira Announces FDA Approval of Topotecan Injection
    2. Hospira Reports Fourth-Quarter and Full-Year 2010 Results
    3. Hospira to Host Conference Call for Fourth-Quarter 2010 Results and 2011 Projections
    4. Hospira Launches Piperacillin and Tazobactam for Injection in the United States
    5. Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and Equipment
    6. Hospira to Host Conference Call for Third-Quarter 2010 Results
    7. Hospira Receives TGA Approval for Nivestim™, Australias First Biosimilar Filgrastim
    8. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
    9. Hospira Announces CEO Succession Plan
    10. Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12
    11. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
    (Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
    (Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
    Breaking Medicine Technology:
    (Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
    (Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
    (Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
    (Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
    (Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
    Breaking Medicine News(10 mins):